Abstract
Objective To determine the associated factors with mortality, in addition to age and sex, in a high-complexity hospital in Bogota, Colombia, during the first year of the pandemic.
Design A case-control study.
Setting High-complexity center above 2,640 meters above sea level (masl) in Colombia.
Methods A case-control study was conducted on 564 patients admitted to the hospital with confirmed COVID-19. Deceased patients (n: 282) and a control group (n: 282), matched by age, sex, and month of admission, were included. Clinical and paraclinical variables were retrospectively obtained by systematic revision of clinical records. Multiple imputations by chained equation (MICE) were implemented to account for missing variables. Classification and regression trees (CART) were estimated to evaluate the interaction of associated factors on admission and their role in predicting mortality during hospitalization.
Results Most of the patients included were males in the seventh decade of life. Most of the admissions occurred between July and August 2021. Surprisingly, recovered patients reported heterogeneous symptomatology, whereas deceased patients were most likely to present respiratory distress, dyspnea, and seizures on admission. In addition, the latter group exhibited a higher burden of comorbidities and alterations in laboratory parameters. After the imputation of datasets, CART analysis estimated 14 clinical profiles based on respiratory distress, LDH, dyspnea, hemoglobin, D-dimer, ferritin, blood urea nitrogen, C-reactive protein, PaO2/FiO2, dysgeusia, total bilirubin, platelets, and gastroesophageal reflux disease. The accuracy model for prediction was 85.6% (P < 0.0001).
Conclusion Multivariate analysis yielded a reliable model to predict mortality in COVID-19. This analysis revealed new interactions between clinical and paraclinical features in addition to age and sex. Furthermore, this predictive model could offer new clues for the personalized management of this condition in clinical settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Clinical del Occidente (Bogota, Colombia) gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of Abbreviations
- ARBs
- Angiotensin II receptor blockers.
- ARDS
- Acute respiratory distress syndrome.
- BUN
- Blood urea nitrogen.
- CART
- Classification and regression trees.
- COVID-19
- Coronavirus disease 2019.
- CRP
- C-reactive protein.
- FiO2
- Fraction of inspired oxygen.
- GERD
- Gastroesophageal reflux disease
- HIV
- Human immunodeficiency.
- ICU
- Intensive care unit.
- IL-1
- Interleukin 1.
- IL-6
- Interleukin 6.
- IQR
- Interquartile range.
- LDH
- Lactate dehydrogenase.
- LOS
- Length of stay.
- Masl
- Meters above sea level.
- MICE
- Multiple imputations by chained equation.
- MV
- Mechanical ventilation.
- NSAIDs
- Non-steroidal anti-inflammatory drugs.
- PaO2/FiO2
- partial pressure of oxygen (PaO2) to inspired (FiO2) partial pressure of oxygen ratio.
- RT-PCR
- Reverse transcriptase-polymerase chain reaction.
- S/F
- Ratio of oxygen saturation to fraction-inspired of oxygen.
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2.
- TBC
- Tuberculosis.
- TBIL
- Total bilirubin levels.
- TNFα
- Tumor necrosis factor-α.
- WHO
- World health organization.
